|
US2920999A
(en)
|
1957-06-07 |
1960-01-12 |
Pfizer & Co C |
21-nitrogen derivatives of corticosteroids
|
|
GB889766A
(en)
|
1958-03-04 |
1962-02-21 |
Olin Mathieson |
Improvements in steroids and the synthesis thereof
|
|
DE1165595B
(de)
|
1958-03-04 |
1964-03-19 |
Olin Mathieson |
Verfahren zur Herstellung von Triamcinolonacetonid-21-hemisuccinat und dessen Salzen
|
|
US3197469A
(en)
|
1958-08-06 |
1965-07-27 |
Pharmaceutical Res Products In |
16, 17-acetals and ketals of 6-halo-16, 17-dihydroxy steroids of the pregnane seriesand intermediates therefor
|
|
US3007923A
(en)
|
1959-01-22 |
1961-11-07 |
Lab Francais Chimiotherapie |
Process for the fluorination of 9beta, 11beta-epoxy and 5alpha, 6alpha-epoxy steroids
|
|
GB898291A
(en)
|
1959-03-18 |
1962-06-06 |
Upjohn Co |
Improvements in or relating to steroids and the manufacture thereof
|
|
US3033873A
(en)
|
1960-05-11 |
1962-05-08 |
Pfizer & Co C |
21-aminomethyl-pregnenes
|
|
US3033874A
(en)
|
1960-05-11 |
1962-05-08 |
Pfizer & Co C |
17beta-propenoyl steroids and process for preparing same
|
|
US3020275A
(en)
|
1960-06-07 |
1962-02-06 |
American Cyanamid Co |
21-nitrogen substituted steroids of the pregnane series and methods of preparing the same
|
|
DE1169444B
(de)
|
1961-02-22 |
1964-05-06 |
Schering Ag |
Verfahren zur Herstellung von ?-16ª-Methylsteroiden
|
|
US3047468A
(en)
|
1961-06-06 |
1962-07-31 |
American Cyanamid Co |
Method of preparing delta1, 4-3-keto steroids of the pregnane series
|
|
US3383394A
(en)
|
1965-08-30 |
1968-05-14 |
Schering Corp |
Novel 17-acylating process and products thereof
|
|
US3798216A
(en)
|
1969-03-07 |
1974-03-19 |
Fabrication Des Antibiotique S |
9-fluoro-11beta,21-dihydroxy-16alpha,17-(2-propenylidenedioxy)-pregna-1,4-diene-3,20-dione and derivatives thereof
|
|
DE2047105C3
(de)
|
1970-09-18 |
1979-02-15 |
Schering Ag, 1000 Berlin Und 4619 Bergkamen |
17-Chlorsteroide und Verfahren zu ihrer Herstellung
|
|
IT1057859B
(it)
|
1972-04-28 |
1982-03-30 |
Sigma Tao Ind Farmaceutiche Sp |
Perivato del triamoinolone
|
|
SE378109B
(https=)
|
1972-05-19 |
1975-08-18 |
Bofors Ab |
|
|
SE378110B
(https=)
|
1972-05-19 |
1975-08-18 |
Bofors Ab |
|
|
US4076737A
(en)
|
1975-02-20 |
1978-02-28 |
Ciba-Geigy Corporation |
Aldehydes of the pregnane series and derivatives thereof
|
|
IL73337A
(en)
|
1984-10-28 |
1988-09-30 |
Yissum Res Dev Co |
Antitumor steroid-platinum complexes and method for the preparation thereof
|
|
SE8604059D0
(sv)
|
1986-09-25 |
1986-09-25 |
Astra Pharma Prod |
A method of controlling the epimeric distribution in the preparation of 16,17-acetals of pregnane derivatives
|
|
IL85035A0
(en)
|
1987-01-08 |
1988-06-30 |
Int Genetic Eng |
Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
|
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
US5116829A
(en)
|
1990-04-23 |
1992-05-26 |
Kao Corporation |
Steroid compounds
|
|
US5183815A
(en)
|
1991-01-22 |
1993-02-02 |
Merck & Co., Inc. |
Bone acting agents
|
|
EP1400536A1
(en)
|
1991-06-14 |
2004-03-24 |
Genentech Inc. |
Method for making humanized antibodies
|
|
NZ259596A
(en)
|
1993-01-08 |
1997-04-24 |
Astra Ab |
Sugar-substituted glucocorticosteroid and use in medicaments specific to the colon or ileum
|
|
DE4311987A1
(de)
|
1993-04-07 |
1994-10-13 |
Schering Ag |
Neue Glucocorticoide
|
|
US5714586A
(en)
|
1995-06-07 |
1998-02-03 |
American Cyanamid Company |
Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates
|
|
US5824669A
(en)
|
1996-03-22 |
1998-10-20 |
Nitromed, Inc. |
Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
|
|
US5837698A
(en)
|
1996-05-02 |
1998-11-17 |
G. D. Searle & Co. |
Steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs
|
|
WO2000049993A2
(en)
|
1999-02-24 |
2000-08-31 |
Nitromed, Inc. |
Nitrosated and nitrosylated steroids for the treatment of cardiovascular diseases and disorders
|
|
US6596541B2
(en)
|
2000-10-31 |
2003-07-22 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
|
US20070258987A1
(en)
|
2000-11-28 |
2007-11-08 |
Seattle Genetics, Inc. |
Recombinant Anti-Cd30 Antibodies and Uses Thereof
|
|
SE0101220D0
(sv)
|
2001-04-04 |
2001-04-04 |
Astrazeneca Ab |
New use
|
|
US6908934B2
(en)
|
2001-06-11 |
2005-06-21 |
Merck & Co., Inc. |
Therapeutic compounds for treating dyslipidemic conditions
|
|
ITMI20020148A1
(it)
|
2002-01-29 |
2003-07-29 |
Nicox Sa |
Nuovi corticosteroidi
|
|
US20050009798A1
(en)
|
2002-02-20 |
2005-01-13 |
Sepracor Inc. |
Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists
|
|
US7190468B2
(en)
|
2002-07-17 |
2007-03-13 |
Hewlett-Packard Development Company, L.P. |
Background document rendering system and method
|
|
DK1545613T3
(da)
|
2002-07-31 |
2011-11-14 |
Seattle Genetics Inc |
Auristatinkonjugater og deres anvendelse til behandling af cancer, en autoimmun sygdom eller en infektiøs sygdom
|
|
EP1562627A4
(en)
|
2002-08-23 |
2006-11-02 |
Mclean Hospital Corp |
CORTICOSTEROID CONJUGATES AND ITS USES
|
|
ES2377318T3
(es)
|
2002-09-06 |
2012-03-26 |
Cerulean Pharma Inc. |
Polímeros a base de ciclodextrina para el suministro de los agentes terapéuticos enlazados covalentemente a ellos
|
|
CN1414008A
(zh)
|
2002-10-17 |
2003-04-30 |
南开大学 |
含氮甾体化合物及其制备方法
|
|
US7015349B2
(en)
|
2003-03-26 |
2006-03-21 |
The Gillette Company |
Reduction of hair growth
|
|
EP2478912B1
(en)
|
2003-11-06 |
2016-08-31 |
Seattle Genetics, Inc. |
Auristatin conjugates with anti-HER2 or anti-CD22 antibodies and their use in therapy
|
|
WO2005063777A1
(en)
|
2003-12-23 |
2005-07-14 |
Corus Pharma |
Benzylphosphate and substituted benzylphosphate prodrugs for the treatment of pulmonary inflammation
|
|
US8101714B2
(en)
*
|
2004-02-18 |
2012-01-24 |
The University Of Georgia Research Foundation, Inc. |
Teleost derived antimicrobial polypeptides
|
|
CA2556752C
(en)
|
2004-02-23 |
2016-02-02 |
Genentech, Inc. |
Heterocyclic self-immolative linkers and conjugates
|
|
US20050192257A1
(en)
|
2004-02-26 |
2005-09-01 |
Peyman Gholam A. |
Predictors for patients at risk for glaucoma from steroid therapy
|
|
AR048098A1
(es)
|
2004-03-15 |
2006-03-29 |
Wyeth Corp |
Conjugados de caliqueamicina
|
|
NZ579482A
(en)
|
2004-06-01 |
2011-02-25 |
Genentech Inc |
Antibody drug conjugates and methods
|
|
EP1602931A1
(en)
|
2004-06-03 |
2005-12-07 |
Universiteit Leiden |
SR-A antagonists
|
|
US7541330B2
(en)
|
2004-06-15 |
2009-06-02 |
Kosan Biosciences Incorporated |
Conjugates with reduced adverse systemic effects
|
|
DE602004017164D1
(de)
|
2004-08-09 |
2008-11-27 |
Deutsches Krebsforsch |
Albuminkonjugate, die eine Glucuron-Verknüpfung enthalten
|
|
TW200616604A
(en)
|
2004-08-26 |
2006-06-01 |
Nicholas Piramal India Ltd |
Nitric oxide releasing prodrugs containing bio-cleavable linker
|
|
JP2008521828A
(ja)
|
2004-11-29 |
2008-06-26 |
シアトル ジェネティックス， インコーポレイテッド |
操作された抗体およびイムノコンジュゲート
|
|
WO2006135371A1
(en)
|
2005-06-09 |
2006-12-21 |
Kosan Biosciences Incorporated |
Conjugates with reduced adverse systemic effects
|
|
WO2006138212A1
(en)
|
2005-06-14 |
2006-12-28 |
Gilead Sciences, Inc. |
SUBSTITUTED PHENYLPHOSPHATES AS MUTUAL PRODRUGS OF STEROIDS AND β -AGONISTS FOR THE TREATMENT OF PULMONARY INFLAMMATION AND BRONCHOCONSTRICTION
|
|
US7750116B1
(en)
|
2006-02-18 |
2010-07-06 |
Seattle Genetics, Inc. |
Antibody drug conjugate metabolites
|
|
JP5307708B2
(ja)
|
2006-06-02 |
2013-10-02 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッド |
ヒトｉｌ−６受容体に対する高親和性抗体
|
|
US8354508B2
(en)
*
|
2006-07-21 |
2013-01-15 |
Diadexus, Inc. |
PRO115 antibody compositions and methods of use
|
|
EP2109617A1
(en)
|
2007-02-05 |
2009-10-21 |
Nicox S.A. |
Nitric oxide releasing steroids
|
|
WO2008122039A2
(en)
|
2007-04-02 |
2008-10-09 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Selenocysteine mediated hybrid antibody molecules
|
|
EP2167963B1
(en)
|
2007-05-23 |
2019-04-17 |
Ventana Medical Systems, Inc. |
Polymeric carriers for immunohistochemistry and in situ hybridization
|
|
CN101784565B
(zh)
|
2007-06-25 |
2014-12-10 |
恩多塞特公司 |
含有亲水性间隔区接头的共轭物
|
|
WO2009001364A2
(en)
|
2007-06-28 |
2008-12-31 |
Capsutech Ltd |
Targeting conjugates comprising active agents encapsulated in cyclodextrin-containing polymers
|
|
CN101397328A
(zh)
|
2007-09-27 |
2009-04-01 |
天津药业研究院有限公司 |
一氧化氮供体型糖皮质激素
|
|
PL2214646T3
(pl)
|
2007-10-05 |
2021-12-20 |
Wayne State University |
Dendrymery do przedłużonego uwalniania związków
|
|
WO2009085879A2
(en)
|
2007-12-21 |
2009-07-09 |
Schering Corporation |
C20-c21 substituted glucocorticoid receptor agonists
|
|
EP2235035A2
(en)
|
2007-12-21 |
2010-10-06 |
Schering Corporation |
C-21 thioethers as glucocorticoid receptor agonists
|
|
SG189817A1
(en)
|
2008-04-30 |
2013-05-31 |
Immunogen Inc |
Potent conjugates and hydrophilic linkers
|
|
TW201010707A
(en)
|
2008-06-10 |
2010-03-16 |
Gilead Sciences Inc |
Corticosteroid linked beta-agonist compounds for use in therapy
|
|
AU2009275358C1
(en)
|
2008-07-21 |
2015-09-24 |
Polytherics Limited |
Novel reagents and method for conjugating biological molecules
|
|
WO2010010119A1
(en)
*
|
2008-07-22 |
2010-01-28 |
Ablynx Nv |
Amino acid sequences directed against multitarget scavenger receptors and polypeptides
|
|
WO2010104187A1
(ja)
|
2009-03-09 |
2010-09-16 |
三笠製薬株式会社 |
ステロイド化合物
|
|
WO2010126953A1
(en)
|
2009-04-29 |
2010-11-04 |
Gilead Sciences, Inc. |
Corticosteroid linked beta-agonist compounds for use in therapy
|
|
WO2010132743A1
(en)
|
2009-05-15 |
2010-11-18 |
Gilead Sciences, Inc. |
Corticosteroid beta-agonist compounds for use in therapy
|
|
AU2010283632B2
(en)
|
2009-08-10 |
2016-08-25 |
Ucl Business Plc |
Reversible covalent linkage of functional molecules
|
|
WO2011020107A2
(en)
|
2009-08-14 |
2011-02-17 |
Georgetown University |
Compositions and methods for detection and treatment of breast cancer
|
|
GB0917054D0
(en)
|
2009-09-29 |
2009-11-11 |
Cytoguide As |
Agents, uses and methods
|
|
GB0917044D0
(en)
|
2009-09-29 |
2009-11-18 |
Cytoguide As |
Agents, uses and methods
|
|
WO2011081937A1
(en)
|
2009-12-15 |
2011-07-07 |
Gilead Sciences, Inc. |
Corticosteroid-beta-agonist-muscarinic antagonist compounds for use in therapy
|
|
US20110178287A1
(en)
|
2010-01-19 |
2011-07-21 |
Cerulean Pharma Inc. |
Cyclodextrin-based polymers for therapeutic delivery
|
|
EP2536432B1
(en)
*
|
2010-02-19 |
2018-08-08 |
Cornell University |
Method to treat autoimmune demyelinating diseases and other autoimmune or inflammatory diseases
|
|
SI2528625T1
(sl)
|
2010-04-15 |
2013-11-29 |
Spirogen Sarl |
Pirolobenzodiazepini in njihovi konjugati
|
|
US20130244905A1
(en)
|
2010-07-06 |
2013-09-19 |
Ed Grabczyk |
Reporter for RNA Polymerase II Termination
|
|
CA2806258A1
(en)
|
2010-07-23 |
2012-01-26 |
Takeda Pharmaceutical Company Limited |
Fused heterocyclic compound and application thereof
|
|
SMT201700023T1
(it)
|
2010-08-02 |
2017-03-08 |
Regeneron Pharma |
Topi che producono proteine leganti vl
|
|
RS53519B1
(sr)
|
2010-09-01 |
2015-02-27 |
Bayer Intellectual Property Gmbh |
N-(tetrazol-5-il)- i n-(triazol-5-il)aril amidi karboksilne kiseline i njihova upotreba kao herbicida
|
|
EA201390575A1
(ru)
|
2010-10-29 |
2014-01-30 |
Иммьюноджен, Инк. |
Неантагонистические egfr-связывающие молекулы и их иммуноконъюгаты
|
|
WO2012145632A1
(en)
|
2011-04-21 |
2012-10-26 |
Cerulean Pharma Inc. |
Cyclodextrin-based polymers for therapeutic delivery
|
|
CN110078789A
(zh)
|
2011-05-27 |
2019-08-02 |
Ambrx 公司 |
含有非天然氨基酸连接的海兔毒素衍生物的组合物、涉及该海兔毒素衍生物的方法及其用途
|
|
US8815226B2
(en)
|
2011-06-10 |
2014-08-26 |
Mersana Therapeutics, Inc. |
Protein-polymer-drug conjugates
|
|
CA2850373C
(en)
|
2011-10-14 |
2019-07-16 |
Seattle Genetics, Inc. |
Pyrrolobenzodiazepines and targeted conjugates
|
|
CN103997893B
(zh)
|
2011-10-14 |
2019-04-12 |
西雅图基因公司 |
吡咯并苯并二氮杂卓和靶向结合物
|
|
BR112014009070B1
(pt)
|
2011-10-14 |
2021-11-23 |
Medimmune Limited |
Método de síntese e intermediários úteis na preparação de pirrolobenzo-diazepinas
|
|
EP2751111B1
(en)
|
2011-10-14 |
2017-04-26 |
MedImmune Limited |
Asymmetrical bis-(5H-Pyrrolo[2,1-c][1,4]benzodiazepin-5-one) derivatives for the treatment of proliferative or autoimmune diseases
|
|
WO2013068874A1
(en)
|
2011-11-11 |
2013-05-16 |
Pfizer Inc. |
Antibody-drug conjugates
|
|
RU2014124984A
(ru)
|
2011-12-05 |
2016-01-27 |
Идженика Биотерапьютикс, Инк. |
Конъюгаты антитело-лекарственное средство и родственные соединения, композиции и способы
|
|
GB201122325D0
(en)
|
2011-12-23 |
2012-02-01 |
Cytoguide As |
Novel formulations
|
|
EP2825553B1
(en)
|
2012-03-14 |
2018-07-25 |
Regeneron Pharmaceuticals, Inc. |
Multispecific antigen-binding molecules and uses thereof
|
|
CN104619350A
(zh)
|
2012-06-14 |
2015-05-13 |
Ambrx公司 |
结合到核受体配体多肽的抗psma抗体
|
|
MY186106A
(en)
|
2012-10-11 |
2021-06-22 |
Ascendis Pharma As |
Diagnosis, prevention and treatment of diseases of the joint
|
|
BR112015008365A2
(pt)
|
2012-10-16 |
2017-07-04 |
Endocyte Inc |
composto da fórmula b-l(d)x, ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um composto, composição de forma de dosagem unitária ou dose unitária, composição para tratar um câncer em um paciente, e método para tratar um câncer em um paciente
|
|
CN105142672B
(zh)
|
2012-10-23 |
2019-04-05 |
西纳福克斯股份有限公司 |
经修饰的抗体、抗体-缀合物及其制备方法
|
|
US9376420B2
(en)
|
2012-10-25 |
2016-06-28 |
Yuhan Corporation |
4,5-dihydro-1H-pyrazole derivative or salts thereof, and pharmaceutical composition comprising same
|
|
CA2896058A1
(en)
|
2012-12-24 |
2014-07-03 |
Abbvie Inc. |
Prolactin receptor binding proteins and uses thereof
|
|
AU2014248640B2
(en)
|
2013-03-13 |
2018-03-01 |
Seagen Inc. |
Cyclodextrin and antibody-drug conjugate formulations
|
|
EP2988786A4
(en)
|
2013-04-22 |
2016-12-21 |
Avelas Biosciences Inc |
COMPOSITIONS FOR SELECTIVE DRUG ADMINISTRATION AND METHOD OF USE
|
|
WO2014197854A1
(en)
|
2013-06-06 |
2014-12-11 |
Igenica Biotherapeutics, Inc. |
Novel linkers for antibody-drug conjugates and related compounds, compositions, and methods of use
|
|
CN105517577A
(zh)
|
2013-06-21 |
2016-04-20 |
先天制药公司 |
多肽的酶促偶联
|
|
US20160158369A1
(en)
|
2013-07-10 |
2016-06-09 |
Seikagaku Corporation |
Pharmaceutical composition for respiratory administration
|
|
TWI641620B
(zh)
|
2013-08-21 |
2018-11-21 |
再生元醫藥公司 |
抗－ｐｒｌｒ抗體及其用途
|
|
NZ758049A
(en)
|
2013-10-15 |
2024-03-22 |
Seagen Inc |
Pegylated drug-linkers for improved ligand-drug conjugate pharmacokinetics
|
|
CN103694375B
(zh)
|
2013-12-13 |
2016-10-05 |
北京大学 |
一种三萜-环糊精共价化合物及其制备方法和用途
|
|
WO2015110609A1
(en)
|
2014-01-24 |
2015-07-30 |
Centre National De La Recherche Scientifique |
Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treating e. coli induced inflammatory bowel diseases such as crohn's disease
|
|
US10550190B2
(en)
|
2014-04-04 |
2020-02-04 |
Merck Sharp & Dohme Corp. |
Phosphate based linkers for intracellular delivery of drug conjugates
|
|
KR102445502B1
(ko)
|
2014-04-10 |
2022-09-21 |
다이이찌 산쿄 가부시키가이샤 |
항her3 항체-약물 콘주게이트
|
|
US9951141B2
(en)
|
2014-06-02 |
2018-04-24 |
Regeneron Pharmaceuticals, Inc. |
Antibody-drug conjugates, their preparation and their therapeutic use
|
|
WO2015189478A1
(en)
|
2014-06-13 |
2015-12-17 |
Glykos Finland Oy |
Payload-polymer-protein conjugates
|
|
RU2017118792A
(ru)
|
2014-12-03 |
2019-01-09 |
Дженентек, Инк. |
Конъюгаты антитела к staphylococcus aureus с рифамицином и их применение
|
|
HK1243931A1
(zh)
|
2014-12-03 |
2018-07-27 |
F. Hoffmann-La Roche Ag |
抗金黄色葡萄球菌抗体利福霉素缀合物及其用途
|
|
CN107207553A
(zh)
|
2014-12-09 |
2017-09-26 |
艾伯维公司 |
Bcl‑xl抑制性化合物和包括其的抗体药物缀合物
|
|
CN111620861A
(zh)
|
2014-12-09 |
2020-09-04 |
艾伯维公司 |
具有低细胞渗透性的bcl-xl抑制性化合物以及包括它的抗体药物缀合物
|
|
EP3250211B1
(en)
|
2015-01-30 |
2021-12-22 |
Coral Drugs Pvt. Ltd. |
Novel process for preparation of glucocorticoid steroids
|
|
US20170224835A1
(en)
|
2015-02-06 |
2017-08-10 |
Sorrento Therapeutics, Inc. |
Antibody Drug Conjugates
|
|
IL296285A
(en)
*
|
2015-07-06 |
2022-11-01 |
Regeneron Pharma |
Multispecific antigen-binding molecules and uses thereof
|
|
WO2017006279A1
(en)
|
2015-07-08 |
2017-01-12 |
Aten Porus Lifesciences |
Cyclodextrin-polymer complexes and compostions and methods of making and using the same
|
|
WO2017044983A1
(en)
|
2015-09-10 |
2017-03-16 |
Shasqi, Inc. |
Bioorthogonal compositions
|
|
US11510993B2
(en)
|
2015-10-06 |
2022-11-29 |
Merck Sharp & Dohme Llc |
Antibody drug conjugate for anti-inflammatory applications
|
|
US10869929B2
(en)
|
2016-01-29 |
2020-12-22 |
Merck Sharp & Dohme Corp. |
Phosphonate linkers and their use to facilitate cellular retention of compounds
|
|
EP3419670A2
(en)
|
2016-02-26 |
2019-01-02 |
Regeneron Pharmaceuticals, Inc. |
Optimized transglutaminase site-specific antibody conjugation
|
|
CN109843919A
(zh)
|
2016-03-25 |
2019-06-04 |
西雅图基因公司 |
用于制备聚乙二醇化的药物-接头及其中间体的方法
|
|
GB201608936D0
(en)
|
2016-05-20 |
2016-07-06 |
Polytherics Ltd |
Novel conjugates and novel conjugating reagents
|
|
US20180126000A1
(en)
|
2016-06-02 |
2018-05-10 |
Abbvie Inc. |
Glucocorticoid receptor agonist and immunoconjugates thereof
|
|
US20200147235A1
(en)
|
2016-06-08 |
2020-05-14 |
Abbvie Inc. |
Anti-cd98 antibodies and antibody drug conjugates
|
|
MY199468A
(en)
|
2016-09-23 |
2023-10-31 |
Regeneron Pharma |
Anti-steap2 antibodies, antibody-drug conjugates, and bispecific antigen-binding molecules that bind steap2 and cd3, and uses thereof
|
|
ES3046537T3
(en)
|
2016-11-08 |
2025-12-02 |
Regeneron Pharma |
Steroids and protein-conjugates thereof
|
|
TWI781145B
(zh)
|
2017-02-28 |
2022-10-21 |
美商伊繆諾金公司 |
具有自分解肽連接子之類美登素衍生物及其結合物
|
|
KR20200007905A
(ko)
|
2017-05-18 |
2020-01-22 |
리제너론 파마슈티칼스 인코포레이티드 |
사이클로덱스트린 단백질 약물 접합체
|
|
WO2018213082A1
(en)
|
2017-05-18 |
2018-11-22 |
Regeneron Pharmaceuticals, Inc. |
Bis-octahydrophenanthrene carboxamides and protein conjugates thereof
|
|
WO2018218004A1
(en)
|
2017-05-24 |
2018-11-29 |
The Board Of Regents Of The University Of Texas System |
Linkers for antibody drug conjugates
|
|
WO2019034176A1
(zh)
|
2017-08-18 |
2019-02-21 |
四川百利药业有限责任公司 |
一种喜树碱-抗体偶联物
|
|
WO2019034177A1
(zh)
|
2017-08-18 |
2019-02-21 |
四川百利药业有限责任公司 |
具有两种不同药物的抗体药物偶联物
|
|
MX2020004691A
(es)
|
2017-11-07 |
2020-08-20 |
Regeneron Pharma |
Enlazadores hidrofilicos para conjugados anticuerpo-farmaco.
|
|
SG11202006510XA
(en)
|
2018-01-08 |
2020-08-28 |
Regeneron Pharma |
Steroids and antibody-conjugates thereof
|
|
BR112020020466A2
(pt)
|
2018-04-06 |
2021-01-12 |
Seattle Genetics, Inc. |
Conjugados de peptídeo de camptotecina
|
|
CN118955710A
(zh)
|
2018-05-09 |
2024-11-15 |
里珍纳龙药品有限公司 |
抗msr1抗体及其使用方法
|
|
IL283313B2
(en)
|
2018-11-20 |
2025-08-01 |
Regeneron Pharma |
Bis-octahydrophenanthrene carboxamide derivatives and protein conjugates thereof for use as lxr agonists
|
|
PH12021551476A1
(en)
|
2018-12-21 |
2022-04-25 |
Regeneron Pharma |
Rifamycin analogs and antibody-drug conjugates thereof
|
|
US20230119539A1
(en)
|
2019-01-08 |
2023-04-20 |
Regeneron Pharmaceuticals, Inc. |
Traceless linkers and protein-conjugates thereof
|
|
BR112021013464A2
(pt)
|
2019-01-08 |
2021-09-21 |
Regeneron Pharmaceuticals, Inc. |
Ligantes sem traço e conjugados de proteína dos mesmos
|